Authors:
Feuerherm, AJ
Borset, M
Seidel, C
Sundan, A
Leistad, L
Ostensen, M
Faxvaag, A
Citation: Aj. Feuerherm et al., Elevated levels of osteoprotegerin (OPG) and hepatocyte growth factor (HGF) in rheumatoid arthritis, SC J RHEUM, 30(4), 2001, pp. 229-234
Authors:
Seidel, C
Hjertner, O
Abildgaard, N
Heickendorff, L
Hjorth, M
Westin, J
Nielsen, JL
Hjorth-Hansen, H
Waage, A
Sundan, A
Borset, M
Citation: C. Seidel et al., Serum osteoprotegerin levels are reduced in patients with multiple myelomawith lytic bone disease, BLOOD, 98(7), 2001, pp. 2269-2271
Authors:
Hjertner, O
Hjorth-Hansen, H
Borset, M
Seidel, C
Waage, A
Sundan, A
Citation: O. Hjertner et al., Bone morphogenetic protein-4 inhibits proliferation and induces apoptosis of multiple myeloma cells, BLOOD, 97(2), 2001, pp. 516-522
Authors:
Flo, TH
Halaas, O
Lien, E
Ryan, L
Teti, G
Golenbock, DT
Sundan, A
Espevik, T
Citation: Th. Flo et al., Human Toll-like receptor 2 mediates monocyte activation by Listeria monocytogenes, but not by group B streptococci or lipopolysaccharide, J IMMUNOL, 164(4), 2000, pp. 2064-2069
Authors:
Flo, TH
Ryan, L
Kilaas, L
Skjak-Braek, G
Ingalls, RR
Sundan, A
Golenbock, DT
Espevik, T
Citation: Th. Flo et al., Involvement of CD14 and beta 2-integrins in activating cells with soluble and particulate lipopolysaccharides and mannuronic acid polymers, INFEC IMMUN, 68(12), 2000, pp. 6770-6776
Authors:
Hjertner, O
Qvigstad, G
Hjorth-Hansen, H
Seidel, C
Woodliff, J
Epstein, J
Waage, A
Sundan, A
Borset, M
Citation: O. Hjertner et al., Expression of urokinase plasminogen activator and the urokinase plasminogen activator receptor in myeloma cells, BR J HAEM, 109(4), 2000, pp. 815-822
Authors:
Seidel, C
Borset, M
Hjertner, O
Cao, DJ
Abildgaard, N
Hjorth-Hansen, H
Sanderson, RD
Waage, A
Sundan, A
Citation: C. Seidel et al., High levels of soluble syndecan-1 in myeloma-derived bone marrow: modulation of hepatocyte growth factor activity, BLOOD, 96(9), 2000, pp. 3139-3146
Authors:
Johnsen, AC
Haux, J
Steinkjer, B
Nonstad, U
Egeberg, K
Sundan, A
Ashkenazi, A
Espevik, T
Citation: Ac. Johnsen et al., Regulation of Apo-2 ligand/trail expression in NK cells - Involvement in NK cell-mediated cytotoxicity, CYTOKINE, 11(9), 1999, pp. 664-672
Authors:
Borset, M
Seidel, C
Hjorth-Hansen, H
Waage, A
Sundan, A
Citation: M. Borset et al., The role of hepatocyte growth factor and its receptor c-Met in multiple myeloma and other blood malignancies, LEUK LYMPH, 32(3-4), 1999, pp. 249-256
Authors:
Borset, M
Hjorth-Hansen, H
Johnsen, AC
Seidel, C
Waage, A
Espevik, T
Sundan, A
Citation: M. Borset et al., Apoptosis, proliferation and NF-kappa B activation induced by agonistic Fas antibodies in the human myeloma cell line OH-2: amplification of Fas-mediated apoptosis by tumor necrosis factor, EUR J HAEMA, 63(5), 1999, pp. 345-353
Authors:
Hjorth-Hansen, H
Seidel, C
Lamvik, J
Borset, M
Sundan, A
Waage, A
Citation: H. Hjorth-hansen et al., Elevated serum concentrations of hepatocyte growth factor in acute myelocytic leukaemia, EUR J HAEMA, 62(2), 1999, pp. 129-134
Authors:
Hjorth-Hansen, H
Seifert, MF
Borset, M
Aarset, H
Ostlie, A
Sundan, A
Waage, A
Citation: H. Hjorth-hansen et al., Marked osteoblastopenia and reduced bone formation in a model of multiple myeloma bone disease in severe combined immunodeficiency mice, J BONE MIN, 14(2), 1999, pp. 256-263
Authors:
Haux, J
Johnsen, AC
Steinkjer, B
Egeberg, K
Sundan, A
Espevik, T
Citation: J. Haux et al., The role of interleukin-2 in regulating the sensitivity of natural killer cells for Fas-mediated apoptosis, CANCER IMMU, 48(2-3), 1999, pp. 139-146
Authors:
Seidel, C
Hjorth-Hansen, H
Bendz, B
Borset, M
Sandset, PM
Hansen, JB
Sundan, A
Waage, A
Citation: C. Seidel et al., Hepatocyte growth factor in serum after injection of unfractionated and low molecular weight heparin in healthy individuals, BR J HAEM, 105(3), 1999, pp. 641-647
Authors:
Hjertner, O
Torgersen, ML
Seidel, C
Hjorth-Hansen, H
Waage, A
Borset, M
Sundan, A
Citation: O. Hjertner et al., Hepatocyte growth factor (HGF) induces interleukin-11 secretion from osteoblasts: A possible role for HGF in myeloma-associated osteolytic bone disease, BLOOD, 94(11), 1999, pp. 3883-3888